BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 26719015)

  • 1. Testosterone Therapy in Men With Prostate Cancer.
    Kaplan AL; Hu JC; Morgentaler A; Mulhall JP; Schulman CC; Montorsi F
    Eur Urol; 2016 May; 69(5):894-903. PubMed ID: 26719015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone Therapy on Active Surveillance and Following Definitive Treatment for Prostate Cancer.
    Golla V; Kaplan AL
    Curr Urol Rep; 2017 Jul; 18(7):49. PubMed ID: 28589395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new era of testosterone and prostate cancer: from physiology to clinical implications.
    Khera M; Crawford D; Morales A; Salonia A; Morgentaler A
    Eur Urol; 2014 Jan; 65(1):115-23. PubMed ID: 24011426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone therapy in men with untreated prostate cancer.
    Morgentaler A; Lipshultz LI; Bennett R; Sweeney M; Avila D; Khera M
    J Urol; 2011 Apr; 185(4):1256-60. PubMed ID: 21334649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone therapy for men at risk for or with history of prostate cancer.
    Morgentaler A
    Curr Treat Options Oncol; 2006 Sep; 7(5):363-9. PubMed ID: 16904053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone therapy in men with prostate cancer: scientific and ethical considerations.
    Morgentaler A
    J Urol; 2009 Mar; 181(3):972-9. PubMed ID: 19150547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone replacement therapy following the diagnosis of prostate cancer: outcomes and utilization trends.
    Kaplan AL; Trinh QD; Sun M; Carter SC; Nguyen PL; Shih YT; Marks LS; Hu JC
    J Sex Med; 2014 Apr; 11(4):1063-1070. PubMed ID: 24443943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of prostate cancer by androgens: experimental paradox or clinical reality.
    Algarté-Génin M; Cussenot O; Costa P
    Eur Urol; 2004 Sep; 46(3):285-94; discussion 294-5. PubMed ID: 15306098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone replacement therapy and the risk of prostate cancer.
    Warburton D; Hobaugh C; Wang G; Lin H; Wang R
    Asian J Androl; 2015; 17(6):878-81; discussion 880. PubMed ID: 25865848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone and prostate cancer: revisiting old paradigms.
    Isbarn H; Pinthus JH; Marks LS; Montorsi F; Morales A; Morgentaler A; Schulman C
    Eur Urol; 2009 Jul; 56(1):48-56. PubMed ID: 19375844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone replacement therapy in prostate cancer patients: is it safe?
    Umbas R; Sugiono M
    Acta Med Indones; 2010 Jul; 42(3):171-5. PubMed ID: 20724773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone therapy in men with prostate cancer: scientific and ethical considerations.
    Morgentaler A
    J Urol; 2013 Jan; 189(1 Suppl):S26-33. PubMed ID: 23234627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Testosterone Flare in the Era of the Saturation Model: One More Historical Myth.
    Krakowsky Y; Morgentaler A
    Eur Urol Focus; 2019 Jan; 5(1):81-89. PubMed ID: 28753828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer risk in testosterone-treated men.
    Raynaud JP
    J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):261-6. PubMed ID: 17113983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone therapy in prostate cancer: is it still a controversy?
    Bart AS; Van Hoof A; Badre-Hume R; Selvarajah J; Robillard K; Albala DM
    Curr Opin Urol; 2022 Nov; 32(6):598-606. PubMed ID: 36081393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone Therapy in Patients with Treated and Untreated Prostate Cancer: Impact on Oncologic Outcomes.
    Ory J; Flannigan R; Lundeen C; Huang JG; Pommerville P; Goldenberg SL
    J Urol; 2016 Oct; 196(4):1082-9. PubMed ID: 27131465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen replacement therapy after prostate cancer treatment.
    Khera M
    Curr Urol Rep; 2010 Nov; 11(6):393-9. PubMed ID: 20838944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations.
    Morgentaler A; Conners WP
    Asian J Androl; 2015; 17(2):206-11. PubMed ID: 25652633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of androgen deficiency and replacement on prostate zonal volumes.
    Jin B; Conway AJ; Handelsman DJ
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):437-45. PubMed ID: 11318778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone Therapy Among Prostate Cancer Survivors.
    Nguyen TM; Pastuszak AW
    Sex Med Rev; 2016 Oct; 4(4):376-88. PubMed ID: 27474995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.